Abstract
Mangiferin, the main active substance of the mango tree bark (Mangifera indica L.), is known for its use in natural medicine, not only as a health enhancing panacea or adjunct therapeutic, but also for brain functions improvement. In this context, we deemed it worthwhile to establish whether mangiferin could traverse into the brain after systemic administration; an essential piece of information for the rational use of a compound as a neurotherapeutic, remaining so far inconclusive regarding mangiferin. We addressed this issue by studying recoverability of mangiferin in membrane and cytosolic fractions of rat brain homogenates after its intraperitoneal administration in a dose of 300 mg/kg. We used three preparations of mangiferin of decreasing purity to find out whether its penetration to the brain could have to do with the possible presence of contaminants. The qualitative methods of thin-layered-chromatography and UV/VIS spectrophotometry were employed in this study. The results were clearly negative, as we failed to trace mangiferin in the brain fractions with either method, which makes it unlikely that the compound traverse the blood-brain barrier after being systemically administered. We conclude that it is improbable that mangiferin could act via direct interaction with central neural components, but rather has peripheral, target specific functions which could be secondarily reflected in brain metabolism.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Beltrán, A. E., Alvarez, Y., Xavier, F. E., Hernanz, R., Rodriguez, J., Núñez, A. J., Alonso, M. J., & Salaices, M. (2004). Vascular effects of the Mangifera indica L. extract (Vimang®). European Journal of Pharmacology, 499, 297–305.
Bhattacharya, S. K., Sanyal, A. K., & Ghosal, S. (1972). Monoamine oxidase-inhibiting activity of mangiferin isolated from Canscora decussata. Naturwissenschaften, 59, 651.
Capote, R., Guardado, I., Novoa, H., Agüero, J., Paneque, A., & Sordo, L. (1998). Chemical-analytical characterization of aqueous extract of Mangifera indica L. Revista Cubana de QuÃmica, 10, 111–112.
Cholbi, M. R., Paya, M., & Alcaraz, M. J. (1991). Inhibitory effect of phenolic compounds on CCL4-induced microsomal lipid peroxidation. Experientia, 472, 195–199.
Chopra, R. N., Nayar, S. L., & Chopra, I. C. (1956). Glossary of Indian medicinal plants (p. 49). New Delhi: CSIR.
Garrido, G., González, D., Lemus, Y., Garcia, D., Lodeiro, L., Quintero, G., Delporte, C., Alberto, J., Núñez-Sellés, A. J., & Delgado, R. (2004). In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (Vimang®). Pharmacological Research, 50, 143–149.
Gómez-Zaleta, B., RamÃrez-Silva, M. T., Gutierréz, A., González-Vergara, E., Güizado-RodrÃguez, M., & Rojas-Hernández, A. (2006). UV/VIS, 1H, and 13C NMR spectroscopic studies to determine mangiferin pKa values. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 64, 1002–1009.
Gottlieb, M., Leal-Campanario, R., Campos-Esparza, M. R., Sánchez-Gómez, M. V., Alberdi, E., Arranz, A., Delgado-Garcıa, J. M., Gruart, A., & Matute, C. (2006). Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia. Neurobiology of Disease, 23, 374–386.
Lai, L., Lin, L.-C., Lin, J.-H., & Tsai, T.-H. (2003). Pharmacokinetic study of free mangiferin in rats by microdialysis coupled with microbore high-performance liquid chromatography and tandem mass spectrometry. Journal of Chromatography. A, 987, 367–374.
Leiro, J., Arranz, J. A., Yanez, M., Ubeira, F. M., Sanmartin, M. L., & Orallo, F. (2004). Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. International Journal of Immunopharmacology, 4, 763–778.
Martinez Sánchez, G., Candelario-Jalil, E., Giuliani, A., León, O. S., Sam, S., Delgado, R., & Núñez-Sellés, A. J. (2001). Mangifera indica L. (QF808) reduces ischaemia induced neuronal loss and oxidative damage in the gerbil brain. Free Radical Research, 35, 465–473.
Miura, T., Ichiki, H., Hashimoto, I., Iwamoto, N., Kato, M., Kubo, M., Ishihara, E., Komatsu, Y., Okada, M., Ishida, T., & Tanigawa, K. (2001). Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine, 8, 85–87.
Muruganandan, S., Lal, J., & Gupta, P. K. (2005a). Immunotherapeutic effects of mangiferin mediated by the inhibition of oxidative stress to activated lymphocytes, neutrophils and macrophages. Toxicology, 215, 57–68.
Muruganandan, S., Srinivasan, K., Gupta, S., Gupta, P. K., & Lal, J. (2005b). Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. Journal of Ethnopharmacology, 97, 497–501.
Núñez-Sellés, A., Vélez-Castro, H., Agüero-Agüero, J., González-González, J., Naddeo, F., De Simone, F., & Rastrelli, L. (2002). Isolation and quantitative analysis of phenolic antioxidants, free sugars, fatty acids and polyols from mango (Mangifera indica L.) stem bark aqueous decoction used in Cuba as nutritional supplement. Journal of Agricultural and Food Chemistry, 50, 762–766.
Pardo-Andreu, G. L., Delgado, R., Núñez-Sellés, A. J., & Vercesi, A. E. (2006a). Vimang® seems to act as an antioxidant by complexing iron ions, rendering them inactive or poorly active in the Fenton reaction. Phytotherapy Research, 20, 120–124.
Pardo-Andreu, G., Philip, S., Riaño, A., Sánchez, C., Viada, C., Núñez-Sellés, A. J., & Delgado, R. (2006b). Mangifera indica L. Vimang® protection against serum oxidative stress in elderly humans. Archives of Medical Research, 37, 158–164.
Pokorski, M., Delgado Hernandez, R., & Rekawek, A. (2010). Mangiferin: A neuroactive polyphenol. 4th International Congress of Pharmacology and Therapeutics; Havana, Cuba. Vaccine vial Monitors, 19(Suppl 2):161.
Sánchez, G. M., Delgado, R., Núñez-Sellés, A. J., Davison, G. P., Garrido, G., & León, O. S. (2000a). Evaluation of the in vitro antioxidant activity of Mangifera indica L. extract (Vimang®). Phytotherapy Research, 14, 424–427.
Sánchez, G. M., Re, L., Giuliani, A., Núñez-Sellés, A. J., Davison, G. P., & León-Fernández, O. S. (2000b). Protective effects of Mangifera indica L. extract, mangiferin and selected antioxidants against TPA-induced biomolecules oxidation and peritoneal macrophage activation in mice. Pharmacological Research, 42, 565–573.
Simpson, I. A., Appel, N. M., Hokari, M., Oki, J., Holman, G. D., Maher, F., Koehler-Stec, E. M., Vannucci, S. J., & Smith, Q. R. (1999). Blood-brain barrier glucose transporter: Effects of hypo- and hyperglycemia revisited. Journal of Neurochemistry, 72, 238–247.
Xu, X., De Pergola, G., Eriksson, P. S., Fu, L., Carlsson, B., Yang, S., Edén, S., & Björntorp, P. (1993). Postreceptor events involved in the up-regulation of beta-adrenergic receptor mediated lipolysis by testosterone in rat white adipocytes. Endocrinology, 132, 1651–1657.
Zajac, D., Matysiak, Z., Czarnocki, Z., & Pokorski, M. (2006). Membrane association of N-oleoyl-dopamine in rat brain. Journal of Physiology and Pharmacology, 57(Suppl 4), 403–408.
Acknowledgments
This research was supported by the statutory budget of the Medical Research Center, Polish Academy of Sciences in Warsaw.
Conflicts of interest: The authors report no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Zajac, D., Stasinska, A., Delgado, R., Pokorski, M. (2013). Mangiferin and Its Traversal into the Brain. In: Pokorski, M. (eds) Respiratory Regulation - The Molecular Approach. Advances in Experimental Medicine and Biology, vol 756. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4549-0_14
Download citation
DOI: https://doi.org/10.1007/978-94-007-4549-0_14
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4548-3
Online ISBN: 978-94-007-4549-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)